BRIEF REPORT
|
doi:10.20944/preprints202304.0364.v1
Subject:
Medicine And Pharmacology,
Epidemiology And Infectious Diseases
Keywords:
ChAdOx1 nCoV-19; immunogenicity; SARS-CoV-2; COVID-19; neutralizing antibodies; durability; booster
Online: 14 April 2023 (10:20:45 CEST)
REVIEW
|
doi:10.20944/preprints202311.1643.v1
Subject:
Public Health And Healthcare,
Health Policy And Services
Keywords:
COVID-19; SARS-CoV-2; vaccine; vaccine efficacy; vaccine effectiveness, vaccine booster; BNT162b2; mRNA1273; Ad26.COV2.S; ChAdOx1-S; SARS-CoV-2 variants
Online: 28 November 2023 (01:41:16 CET)
ARTICLE
|
doi:10.20944/preprints202208.0463.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
COVID-19 vaccines; vaccine effectiveness; BNT162b2 vaccine; mRNA-1273 vaccine; ChAdOx1 vaccine; 19 Elecsys Anti-SARS-CoV-2 S assay; reactogenicity; vaccine-associated symptoms
Online: 26 August 2022 (14:14:39 CEST)
ARTICLE
|
doi:10.20944/preprints202301.0440.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
COVID-19 Vaccines; BNT162 Vaccine; ChAdOx1 nCoV-19; Side Effects and Adverse Reactions; Booster Immunizations; COVID-19; SARS-CoV-2
Online: 25 January 2023 (03:50:52 CET)
ARTICLE
|
doi:10.20944/preprints202203.0411.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
COVID-19; SARS-CoV-2; Vaccines; anti-SARS-CoV-2 spike total antibodies; Surrogate viral neutralizing antibody; T-cell immune response; CoronaVac; ChAdOx1; BNT162b2; booster
Online: 31 March 2022 (14:28:11 CEST)